Founded in 2019, Omini is developing the first point-of-care blood biomarker monitoring platform to transform the lives of patients suffering from chronic diseases, using its unique multiplex electrochemical biosensor technology.
Multiplexing provides personalized blood biomarker data that can be used to adjust therapies and prevent acute crises in patients with chronic conditions.
The affordable device combines a portable reader and single-use test strips, similar to a glucometer, simultaneously measuring four to ten blood biomarkers from a single capillary blood sample. It can be used at home or in outpatient care facilities to help relieve the burden on healthcare systems.
Omini is currently developing the first application of its solution for heart failure patients, a fast-growing disease nicknamed ‘the silent killer.’
Company Details
- Employees
- 55
- Founded
- -
- Address
- 15, Rue Jean-Antoine De Baïf, Paris,île-De-France 75013,france
- jo****@****abs.com
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- ominilabs.com
- HQ
- Paris, Île-de-France
Omini Questions
Omini's website is ominilabs.com
Omini's LinkedIn profile is https://fr.linkedin.com/company/ominilabs
Omini has
55 employees.
View email and phone details for 55
employees at Omini.
Omini's industry is
Medical Equipment Manufacturing
Omini's top competitors are
Station F,
Endogene.bio,
Chipiron,
Omini,
Alchimedics,
Inspek,
Omni Táxi Aéreo,
Omini,
Omni Conectado,
Matricis.ai.
Omini's support email address is joanne@ominilabs.com
Omini's categories are Medical Equipment Manufacturing
Omini's founding year is 2019
